The State of the Art of Pyrazole Derivatives as Monoamine Oxidase Inhibitors and Antidepressant/Anticonvulsant Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|33|5114-5144

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.33, 2011-11, pp. : 5114-5144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis, Biological Evaluation and 3D-QSAR of 1,3,5-Trisubstituted-4,5- Dihydro-(1H)-Pyrazole Derivatives as Potent and Highly Selective Monoamine Oxidase A Inhibitors

By  

Current Medicinal Chemistry, Vol. 13, Iss. 12, 2006-05 ,pp. : 1411-1428

Bentham Science Publishers

Access to resources Recommend Favorite

Monoamine Oxidase Inhibitors as Neuroprotective Agents in Age-Dependent Neurodegenerative Disorders

By  

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2799-2817

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and Optimization of Pyrazoline Derivatives As Promising Monoamine Oxidase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 20, 2012-10 ,pp. : 2240-2257

Bentham Science Publishers

Access to resources Recommend Favorite

Monoamine oxidase A and B inhibitors

By Jegham S.   George P.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 9, 1998-09 ,pp. : 1143-1150

Informa Healthcare

Access to resources Recommend Favorite

Focusing on new monoamine oxidase inhibitors

By Bolasco Adriana   Carradori Simone   Fioravanti Rossella  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 7, 2010-07 ,pp. : 909-939

Informa Healthcare

Access to resources Recommend Favorite